Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.807 | 0.160 | 13 | 46835532 | missense variant | C/A;T | snv | 4.0E-06 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2008 | 2012 | |||||||
|
0.807 | 0.160 | 13 | 46835532 | missense variant | C/A;T | snv | 4.0E-06 |
|
Musculoskeletal Diseases; Nervous System Diseases | 0.010 | < 0.001 | 1 | 2012 | 2012 | |||||||
|
0.807 | 0.160 | 13 | 46835532 | missense variant | C/A;T | snv | 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.807 | 0.160 | 13 | 46835532 | missense variant | C/A;T | snv | 4.0E-06 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||||
|
0.807 | 0.160 | 13 | 46835532 | missense variant | C/A;T | snv | 4.0E-06 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.807 | 0.160 | 13 | 46835532 | missense variant | C/A;T | snv | 4.0E-06 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.160 | 13 | 46835532 | missense variant | C/A;T | snv | 4.0E-06 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.160 | 13 | 46835532 | missense variant | C/A;T | snv | 4.0E-06 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.160 | 13 | 46835532 | missense variant | C/A;T | snv | 4.0E-06 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.160 | 13 | 46835532 | missense variant | C/A;T | snv | 4.0E-06 |
|
0.010 | 1.000 | 1 | 2006 | 2006 | ||||||||
|
0.807 | 0.160 | 13 | 46835532 | missense variant | C/A;T | snv | 4.0E-06 |
|
0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
1.000 | 0.040 | 13 | 46860971 | intron variant | C/G | snv | 0.18 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.925 | 0.080 | 13 | 46834716 | 3 prime UTR variant | C/G;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.925 | 0.080 | 13 | 46834716 | 3 prime UTR variant | C/G;T | snv |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.925 | 0.080 | 13 | 46834716 | 3 prime UTR variant | C/G;T | snv |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.925 | 0.080 | 13 | 46834716 | 3 prime UTR variant | C/G;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Mental Disorders | 0.100 | 0.800 | 10 | 2010 | 2019 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Mental Disorders | 0.060 | 0.833 | 6 | 2007 | 2018 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Mental Disorders | 0.050 | 1.000 | 5 | 2010 | 2019 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Mental Disorders | 0.030 | 0.667 | 3 | 2014 | 2019 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Mental Disorders | 0.030 | 1.000 | 3 | 2017 | 2017 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Behavior and Behavior Mechanisms | 0.020 | 1.000 | 2 | 2006 | 2018 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Chemically-Induced Disorders; Mental Disorders | 0.020 | 1.000 | 2 | 2011 | 2017 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2014 | 2014 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Chemically-Induced Disorders; Mental Disorders | 0.020 | 1.000 | 2 | 2009 | 2014 |